Capital Allocation Signals: Mid-Cap Firms Pivot to Strategic ConsolidationGlobal Report·15 hours agoJSPR-5.58%NOVT-1.20%
U.S. stock night trading volatility: Jasper Therapeutics fell 3% in after-hours trading, with executives disclosing their holdings intensively attracting attentionPrice Alert·23 hours agoJSPR-5.58%
Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filingPUBT·1 day ago, 03:01 PMJSPR-5.58%
U.S. stock night trading volatility: Jasper Therapeutics fell 3.93% in after-hours trading, with executive sell-offs and positive cooperation failing to mask market concernsPrice Alert·1 day ago, 11:46 PMJSPR-5.58%
Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statementPUBT·2 days ago, 06:11 PMJSPR-5.58%
Chime's Expansion and Jasper's M&A Deal Highlight Micro-Catalyst Driven US MarketGlobal Report·2 days ago, 04:17 AMCHYM-0.34%ALLY-2.39%
Pre-market hot trades in US stocks: Jasper Therapeutics pre-market down 4.18%; Salesforce pre-market down 3.64%Price Alert·Jul 21 at 06:22 AMJSPR-5.58%CRM+4.29%
Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statementPUBT·Jul 20 at 07:38 PMJSPR-5.58%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 17 at 12:05 PMAPLM-3.45%APLMW+1.60%
Jasper Completes Kira Acquisition, Raises $132M PIPE and Licenses C5a Programs to MiradorTradingView·Jul 17 at 05:13 AMJSPR-5.58%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Jul 6 at 04:05 PMRXST-3.35%LUCY-6.40%
U.S. stock market midday update: Jasper Therapeutics up 12.32%, active trading without positive newsPrice Alert·Jun 29 at 02:07 PMJSPR-5.58%
